NIAMS Clinical Trial Implementation Cooperative Agreement (U01)

archived

This Funding Opportunity Announcement (FOA) issued by the NIAMS invites cooperative agreement (U01) applications for implementation of investigator -initiated interventional clinical trials (all phases). This U01 FOA, which allows for the electronic submission of applications for single-site projects, compliments the previously released UM1 FOA, which permits submission of paper applications for multi-site projects. Applications for clinical trials submitted to the NIAMS are normally expected to go through a two-part process, which begins with a U34 planning phase (Part 1) followed by an application for the U01. Investigators who have completed all necessary pre-trial planning and preparation through other means may also apply for a NIAMS U01. Consultation with NIAMS staff is strongly encouraged prior to the submission of the clinical trial implementation U01 application. The NIAMS expects such trials to be hypothesis driven, milestone-defined, related to the research mission of the NIAMS, and considered high-priority by the institute.

High